Aprogen Biologics Inc.

KOSE:A003060 Stok Raporu

Piyasa değeri: ₩165.8b

Aprogen Biologics Gelecekteki Büyüme

Future kriter kontrolleri 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Aprogen Biologics.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi38.2%
Gelir büyüme oranın/a
Gelecekteki özkaynak getirisin/a
Analist kapsamı

None

Son güncellemen/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Risks Still Elevated At These Prices As Aprogen Biologics Inc. (KRX:003060) Shares Dive 26%

Jun 20
Risks Still Elevated At These Prices As Aprogen Biologics Inc. (KRX:003060) Shares Dive 26%

More Unpleasant Surprises Could Be In Store For Aprogen Biologics Inc.'s (KRX:003060) Shares After Tumbling 28%

Apr 18
More Unpleasant Surprises Could Be In Store For Aprogen Biologics Inc.'s (KRX:003060) Shares After Tumbling 28%

We Wouldn't Rely On Aprogen pharmaceuticalsInc's (KRX:003060) Statutory Earnings As A Guide

Jan 16
We Wouldn't Rely On Aprogen pharmaceuticalsInc's (KRX:003060) Statutory Earnings As A Guide

Aprogen pharmaceuticals,Inc.'s (KRX:003060) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Dec 20
Aprogen pharmaceuticals,Inc.'s (KRX:003060) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Is Aprogen pharmaceuticalsInc (KRX:003060) A Risky Investment?

Nov 24
Is Aprogen pharmaceuticalsInc (KRX:003060) A Risky Investment?

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Aprogen Biologics yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

KOSE:A003060 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (KRW Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
6/30/202473,635-131,144-45,568-21,521N/A
3/31/202485,518-125,383-49,146-23,551N/A
12/31/202387,364-118,270-62,047-33,651N/A
9/30/202381,744-19,222-48,326-27,045N/A
6/30/202377,627-9,889-31,233-21,337N/A
3/31/202365,77910,9163,71010,117N/A
12/31/202265,19012,63924,18325,728N/A
9/30/202262,48112,17211,55012,324N/A
6/30/202261,13010,38411,29612,245N/A
3/31/202261,0638,984-5,787-4,659N/A
12/31/202156,4828,103-7,169-6,227N/A
9/30/202154,6825,4729,66610,986N/A
6/30/202153,4287,3258,3349,384N/A
3/31/202151,7629,4064,9475,969N/A
12/31/202053,32011,2536,8208,088N/A
9/30/202055,4889,1792,7114,316N/A
6/30/202054,2082,7321992,734N/A
3/31/202053,451512-6731,918N/A
12/31/201950,904-8,315-1,707714N/A
9/30/201949,155-10,212-1,296672N/A
6/30/201947,488-4,357331,151N/A
3/31/201945,681-4,336-2,862907N/A
12/31/201845,395-1,215-9131,331N/A
9/30/201844,5622,033-7,845-5,335N/A
6/30/201845,382-11,476-10,045-7,149N/A
3/31/201845,555-16,232N/A-8,471N/A
12/31/201746,101-16,365N/A-8,928N/A
9/30/201745,925-17,838N/A-2,287N/A
6/30/201745,058-8,987N/A-389N/A
3/31/201745,066-5,953N/A632N/A
12/31/201644,122-3,918N/A450N/A
9/30/201644,322-22N/A-120N/A
6/30/201642,783942N/A-1,114N/A
3/31/201641,3842,848N/A-249N/A
12/31/201540,3242,761N/A1,847N/A
9/30/201536,0261,175N/A-132N/A
6/30/201536,098-410N/A-2,331N/A
3/31/201534,713-2,708N/A-4,360N/A
12/31/201433,092-3,887N/A-6,917N/A
9/30/201429,623-10,481N/A-4,584N/A
6/30/201429,415-10,772N/A-493N/A
3/31/201429,543-16,461N/A-465N/A
12/31/201329,543-20,852N/A-1,702N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if A003060's forecast earnings growth is above the savings rate (2.6%).

Kazançlar ve Piyasa: Insufficient data to determine if A003060's earnings are forecast to grow faster than the KR market

Yüksek Büyüme Kazançları: Insufficient data to determine if A003060's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if A003060's revenue is forecast to grow faster than the KR market.

Yüksek Büyüme Geliri: Insufficient data to determine if A003060's revenue is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if A003060's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin